MarginsXMarginsX
Home › Markets › Health Care › ALDX

Aldeyra Therapeutics Inc. (ALDX)

ALDX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.6696
+4.01% on the day
Market cap
$40.4M
Nano cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerALDX on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2014
SEC CIK0001341235
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

Not reported in SEC XBRL data.

Warning signs

Cash runway
25.7 months
$41.0M cash at September 30, 2026
Share count, 1 year
+0.3%
2025-10-28 to 2026-11-03 · +2.6% over 3 years
Going-concern doubt
No
10-Q filed November 5, 2026
Insider net buying, 12 months
$523K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-05
Cash and burn$41.0M cash; operating cash flow -$4.8M a quarter.Report 2026-09-30
Shares outstanding60,356,541 (2026-11-03); 60,162,773 a year earlier; 58,822,083 three years earlier.Cover page 2026-11-03
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorBDO USA, P.C., Boston, Massachusetts, United StatesPCAOB Form AP 2026-03-02
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $523K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
Not filed-$3.8M-$4.1M$41.0M$0Needs four quarters10-Q 2026-11-05
Q2 2026
2026-06-30
Not filed-$5.5M-$4.6M$45.1M$0Needs four quarters10-Q 2026-08-06
Q1 2026
2026-03-31
Not filed-$3.5M-$5.1M$65.0M$15.3MNeeds four quarters10-Q 2026-05-07
Q4 2025
2025-12-31
Not filed-$6.5M-$5.3M$70.0M$15.3MNeeds four quarters10-K 2026-02-27
Q3 2025
2025-09-30
Not filed-$7.7M-$7.0M$59.3M$15.3MNeeds four quarters10-Q 2026-11-05
Q2 2025
2025-06-30
Not filed-$9.8M-$8.6M$41.2M$15.3MNeeds four quarters10-Q 2026-08-06
Q1 2025
2025-03-31
Not filed-$9.9M-$12.5M$50.4M$15.3MNeeds four quarters10-Q 2026-05-07
Q4 2024
2024-12-31
Not filed-$15.8M-$12.0M$54.5M$15.3MNeeds four quarters10-K 2026-02-27

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52024-08-01
Latest annual report10-K2026-02-27
Latest quarterly / interim10-Q2026-11-05
Latest current report8-K2026-11-09
Latest proxyDEFA14A2026-04-27

Source: SEC EDGAR submissions feed, 653 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+1.6%
1 month-28.4%
3 months-55.3%
Year to date-87.6%
1 year-87.2%
From 52-week high-88.5%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
CNTBConnect Biopharma Holdings Limited$0.6430-5.05%$40.5M
DWTXDogwood Therapeutics Inc.$1.06-8.62%$40.5M
GANXGain Therapeutics Inc.$0.9402-9.60%$41.9M
ELTXElicio Therapeutics Inc.$1.48-1.33%$41.9M
IBOImpact BioMedical Inc.$4.91-4.47%$42.4M
HYPDHyperion DeFi Inc.$2.47-4.26%$38.3M
PLRXPliant Therapeutics Inc.$0.6932-0.55%$43.0M
BMEABiomea Fusion Inc.$0.5201-10.67%$37.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier